All content and product details on this site are for educational purposes only. Products are for in-vitro studies (performed outside the body) and not FDA-approved for medical use. Any introduction into humans or animals is prohibited by law.
Categories
Recent Posts
CJC-1295 Peptide Research: GHRH Analog and Growth Hormone
Explore CJC-1295, a GHRH analog originally developed as an investigational compound. Studies have measured its effects on growth hormone and IGF-1 levels.
PP-TS1: GHRH Analog Research
PP-TS1 is a growth hormone-releasing hormone analog studied for its stability, GHRH-receptor pharmacology and GH/IGF-1 responses. A summary of the published literature.
Peptides and Aging Biology: A Research Overview
Peptides are gaining attention as research tools in aging biology. These short chains of amino acids regulate cellular repair, inflammation, and hormonal balance, processes that are studied in research on age-related conditions. Recent research has examined their interactions with aging mechanisms. This article explores peptides’ role in aging biology research and the challenges facing this field.
Selank Peptide: Anxiolytic and Cognitive Research Explained
Brief Overview/Summary
Explore research on Selank peptide, its role in stress response, anxiety modulation, anxiolytic effect and cognitive function through scientific studies
Selank is a synthetic peptide that is a derivative of the naturally occurring peptide tuftsin. It is known for the anxiolytic-like activity reported in animal studies, which has made it a research compound in studies of stress and anxiety-related behaviour in rodent models [1][2].
This particular peptide, which is referred to as the Selank peptide, is a heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro [1]. It is a synthetic analogue of tuftsin, a tetrapeptide that plays a role in the regulation of the immune system [3]. Much of the published research on Selank comes from groups at the Institute of Molecular Genetics of the Russian Academy of Sciences, where its activity in both the nervous and immune systems has been studied [1][3].
Studies have linked its reported anxiolytic-like activity to effects on the GABAergic system and on enzymes that break down enkephalins [1][4][5]. Selank has also been examined for effects on learning and memory in rats and on the expression of inflammation-related genes in mice [6][7][3].
These areas of study, which include stress-related behaviour, learning, GABAergic signalling and immune-related gene expression, make it a flexible tool for neuroscience and immunology research. One of the most frequently reported findings is a prolonged anti-anxiety-like and nootropic-like profile in animal experiments [1].
Mechanism of Action of Selank Peptide
Selank, a synthetic peptide studied for its anxiolytic-like and immunomodulatory effects, is among the peptides studied in brain function research, with studies examining anxiety-related and cognitive endpoints in animal models [2][6].
In radioligand-binding experiments with brain membrane preparations, Selank affected [3H]GABA binding as a positive allosteric modulator, and its joint action with some benzodiazepines differed from that of either substance alone [1]. In the rat frontal cortex, Selank changed the expression of 45 of 84 neurotransmission-related genes one hour after exposure, and these changes correlated with those produced by GABA; the authors proposed allosteric modulation of the GABAergic system as one of its molecular mechanisms [4].
In cultured IMR-32 neuroblastoma cells, Selank alone did not change the mRNA levels of GABAergic genes, but it modified the gene-expression response to GABA and to the antipsychotic olanzapine [8].
Selank also inhibits enzymes that degrade enkephalins and other regulatory peptides. In human serum in vitro, Selank and the related peptide Semax inhibited enkephalin-degrading enzymes more strongly than the peptidase inhibitors puromycin and bacitracin [5].
The immunomodulatory effects of this peptide have been studied through gene-expression measures. In mouse spleen, Selank and its fragments altered the expression of 34 inflammation-related genes, including the transcriptional regulator Bcl6 [3], and a follow-up study described the time course of changes in C3, Casp1, Il2rg and Xcr1 expression after Selank and its Gly-Pro fragment [9]. In the hippocampus of rats exposed to acute restraint stress, Selank changed gene expression in the first hours after stress [10].
Research Evidence
Research on Selank has examined anxiety-like behaviour in rodent models. In rats under unpredictable chronic mild stress, anxiety indicators were measured in the elevated plus maze after a course of Selank, diazepam or both, and the authors reported that Selank reduced elevated anxiety indicators [2]. Studies comparing ten tuftsin-family peptides and Selank in rats and mice divided by type of emotional reactivity also reported antistress effects in a conflict-situation model [11].
Research on cognitive function has examined Selank's effects on learning and memory in rats. In rats with initially low learning ability, Selank was associated with faster acquisition of a conditioned active-avoidance reflex, with the effect increasing over repeated sessions [6]. In adult rats whose brain catecholamine system had been damaged by a neurotoxin early in life, Selank was associated with restored learning, memory and attention measures [7].
Comparisons between two mouse strains, BALB/c and C57BL/6, reported that whether nootropic-like or anxiolytic-like effects of Selank, Semax and Noopept predominated depended on the experimental conditions [12]. These findings highlight Selank as a synthetic peptide with extensive uses in stress and behavioural research.
Research Application
Selank is studied in neuroscience research on GABAergic signalling, stress responses and learning in animal models [1][4][2]. This research uses animal models and cell-culture systems to evaluate the effects of Selank on behaviour and on the expression of neurotransmission-related genes [4][8].
The immunomodulatory effects of Selank are being investigated by researchers in the field of immune system research. These studies focus on the expression of genes involved in inflammation and immune responses in mouse spleen [3][9].
Comparative studies analyse Selank alongside compounds that act on the GABAergic system, such as benzodiazepines, in receptor-binding, cell-culture and behavioural experiments [1][8][2].
Behavioural assays (such as the elevated plus maze and conditioned avoidance tests), radioligand binding and gene-expression profiling are the approaches used in these research methodologies [1][4][6][2]. Endpoints in this research include anxiety-related behaviour, learning measures and gene expression.
The synthetic nature of the peptide, along with its targeted effect, makes it a useful instrument for research in the fields of neuroscience and immunology.
Future Perspective
Research that is currently being conducted on Selank, a synthetic peptide that is derived from tuftsin, continues to investigate its anxiolytic-like and cognitive effects in animal models and its molecular mechanisms, in particular allosteric modulation of GABA receptors and effects on gene expression [1][4][10].
Open questions include how Selank's effects on GABAergic signalling, on enkephalin-degrading enzymes and on immune-related gene expression relate to one another, and how far findings from rodent models generalise to other systems [1][3][5].
The continuation of research will shed light on Selank's function and expand understanding of bioactive regulatory peptides.
References
Vyunova, T. V., Andreeva, L., Shevchenko, K., & Myasoedov, N. (2018). Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity. Protein and Peptide Letters, 25(10), 914-923. https://doi.org/10.2174/0929866525666180925144642
Kasian, A., Kolomin, T., Andreeva, L., Bondarenko, E., Myasoedov, N., Slominsky, P., & Shadrina, M. (2017). Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats. Behavioural Neurology, 2017, 5091027. https://doi.org/10.1155/2017/5091027
Kolomin, T., Shadrina, M., Andreeva, L., Slominsky, P., Limborska, S., & Myasoedov, N. (2011). Expression of inflammation-related genes in mouse spleen under tuftsin analog Selank. Regulatory Peptides, 170(1-3), 18-23. https://doi.org/10.1016/j.regpep.2011.05.001
Volkova, A., Shadrina, M., Kolomin, T., Andreeva, L., Limborska, S., Myasoedov, N., & Slominsky, P. (2016). Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Frontiers in Pharmacology, 7, 31. https://doi.org/10.3389/fphar.2016.00031
Kost, N. V., Sokolov, O. Y., Gabaeva, M. V., Grivennikov, I. A., Andreeva, L. A., Myasoedov, N. F., & Zozulya, A. A. (2001). Semax and Selank Inhibit the Enkephalin-Degrading Enzymes of Human Serum. Russian Journal of Bioorganic Chemistry, 27(3), 156-159. https://doi.org/10.1023/a:1011373002885
Kozlovskii, I. I., & Danchev, N. D. (2003). The optimizing action of the synthetic peptide Selank on a conditioned active avoidance reflex in rats. Neuroscience and Behavioral Physiology, 33(7), 639-643. https://doi.org/10.1023/a:1024444321191
Semenova, T. P., Kozlovskaya, M. M., Zakharova, N. M., Kozlovskii, I. I., & Zuikov, A. V. (2007). Effect of selank on cognitive processes after damage inflicted to the cerebral catecholamine system during early ontogeny. Bulletin of Experimental Biology and Medicine, 144(5), 689-691. https://doi.org/10.1007/s10517-007-0406-2
Filatova, E., Kasian, A., Kolomin, T., Rybalkina, E., Alieva, A., Andreeva, L., ... & Shadrina, M. (2017). GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells. Frontiers in Pharmacology, 8, 89. https://doi.org/10.3389/fphar.2017.00089
Kolomin, T., Morozova, M., Volkova, A., Shadrina, M., Andreeva, L., Slominsky, P., Limborska, S., & Myasoedov, N. (2014). The temporary dynamics of inflammation-related genes expression under tuftsin analog Selank action. Molecular Immunology, 58(1), 50-55. https://doi.org/10.1016/j.molimm.2013.11.002
Filippenkov, I. B., Glazova, N. Y., Sebentsova, E. A., Mozgovoy, I. V., Stavchansky, V. V., Myasoedov, N. F., ... & Dergunova, L. V. (2024). Selank Peptide Causes Changes in Gene Expression in the Hippocampus of Rats in the Early Hours after Acute Restraint Stress. Nanobiotechnology Reports, 19(3), 381-392. https://doi.org/10.1134/S2635167624601335
Kozlovskaya, M. M., Kozlovskii, I. I., Val'dman, E. A., & Seredenin, S. B. (2003). Selank and short peptides of the tuftsin family in the regulation of adaptive behavior in stress. Neuroscience and Behavioral Physiology, 33(9), 853-860. https://doi.org/10.1023/a:1025988519919
Vasileva, E. V., Kondrakhin, E. A., Abdullina, A. A., Salimov, R. M., & Kovalev, G. I. (2020). Predominance of Nootropic or Anxiolytic Effects of Selank, Semax, and Noopept Peptides Depending on the Route of Administration to BALB/c and С57BL/6 Mice. Neurochemical Journal, 14(3), 268-278. https://doi.org/10.1134/S1819712420030113
Read more about peptides
TB-500 Peptide Research: Cellular Repair and Metabolite Studies
Explore research on TB-500 peptide and its role in tissue remodelling, wound repair, and actin regulation through scientific studies.
GLP-1SM: GLP-1 Receptor Agonist Research
GLP-1SM is a long-acting GLP-1 receptor agonist studied in metabolic research. A summary of its structure, mechanism of action and published preclinical findings.